Skip to main content
. Author manuscript; available in PMC: 2011 Jun 15.
Published in final edited form as: Cancer Res. 2010 May 25;70(12):5096–5108. doi: 10.1158/0008-5472.CAN-09-4148

Table 1.

Differentially expressions of miRNAs 231/E1A cells versus 231/VC cells were analyzed by miRNA microarray analysis and confirmed by qRT-PCR.

Upregulated miRNAs by E1A
miRNA ID microarray qRT-PCR# P-value Function Validated target Refs.
has-mir-377 78.6 3.48±1.39 0.0199* unknown unknown
has-mir-515-3p 12.67 13.87±7.66 0.0102* unknown unknown
has-mir-92 7.7 3.13±0.41 0.0450* unknown unknown
has-mir-18a 6.27 6.93±1.05 0.0121* inhibition cell proliferation K-Ras (53)
has-mir-15b 6.24 5.11±1.04 0.0051** cell proliferation, apoptosis, cell cycle progression cyclin E1 (54), (55)
has-mir-195 4.71 3.24±1.49 0.0583 block G1/S transition cyclin D1, CDK6, E2F3 (56)
has-mir-182 4.18 3.05±0.91 0.0548 transformation or maintenance of an oncogenic state FOXO1 (57)
has-mir-107 4.06 4.26±1.5 0.1035 cell cycle arrest unknown (58)
has-mir-93 3.16 3.77±0.34 0.0806 unknown FUS1 (59)
has-mir-25 3.11 4.74±1.48 0.0878 unknown Krüppel-like factor 4 (KLF4) (60)
Downregulated miRNAs by E1A
miRNA ID microarray qRT-PCR P-value
has-mir-520h 0.01 0.02±0.02 0.0001** stem cell differentiation ABCG2 (61), (62)
has-mir-197 0.02 0.78±0.03 0.0178* unknown FUS1 (63)
Let-7b 0.23 0.30±0.17 0.0365* Induces apoptosis and inhibits tumorigenesis RAS, MYC and HMGA2 (64)
has-mir-27a 0.31 0.33±0.08 0.0352* cancer cell growth, Prohibitin, FOXO1 (65)
#

Each assay was performed in at least three separate experiments. The data were normalized to the level of U47 RNA in each sample.

The asterisk indicates a significant difference between 231/VC and 231/E1A cells.

*

, P < 0.05.

**

P < 0.01.